120 related articles for article (PubMed ID: 8045592)
1. The potential of immunization with synthetic peptides to overcome the immunosuppressive effect of maternal anti-measles virus antibodies in young mice.
Obeid OE; Steward MW
Immunology; 1994 May; 82(1):16-21. PubMed ID: 8045592
[TBL] [Abstract][Full Text] [Related]
2. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
Olszewska W; Obeid OE; Steward MW
Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides.
Partidos CD; Obeid OE; Steward MW
Immunology; 1992 Oct; 77(2):262-6. PubMed ID: 1385315
[TBL] [Abstract][Full Text] [Related]
4. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
Partidos CD; Vohra P; Steward MW
Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies.
El Kasmi KC; Fillon S; Theisen DM; Hartter H; Brons NH; Muller CP
J Gen Virol; 2000 Mar; 81(Pt 3):729-35. PubMed ID: 10675410
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the antigenic profile of measles virus haemagglutinin in mice and humans using overlapping synthetic peptides.
Obeid OE; Partidos CD; Steward MW
Virus Res; 1994 Apr; 32(1):69-84. PubMed ID: 7518172
[TBL] [Abstract][Full Text] [Related]
8. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
9. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
[TBL] [Abstract][Full Text] [Related]
10. Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens.
Pütz MM; Ammerlaan W; Schneider F; Jung G; Muller CP
Vaccine; 2004 Oct; 22(31-32):4173-82. PubMed ID: 15474707
[TBL] [Abstract][Full Text] [Related]
11. [Age-related loss of maternal antibodies against measles in children in La Plata].
del Buono MB; Vaschetti P; Iannicelli J; Silber R
Rev Argent Microbiol; 2003; 35(2):102-5. PubMed ID: 12920993
[TBL] [Abstract][Full Text] [Related]
12. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.
Obeid OE; Partidos CD; Howard CR; Steward MW
J Virol; 1995 Mar; 69(3):1420-8. PubMed ID: 7531779
[TBL] [Abstract][Full Text] [Related]
13. Fine specificity of the antibody response to a synthetic peptide from the fusion protein and protection against measles virus-induced encephalitis in a mouse model.
Partidos CD; Ripley J; Delmas A; Obeid OE; Denbury A; Steward MW
J Gen Virol; 1997 Dec; 78 ( Pt 12)():3227-32. PubMed ID: 9400973
[TBL] [Abstract][Full Text] [Related]
14. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
[TBL] [Abstract][Full Text] [Related]
15. Maternal immunization with a soluble TCR-Ig chimeric protein: long term, V beta-8 family-specific suppression of T cells by maternally transferred antibodies.
McKeever U; Khandekar S; Jesson M; Newcomb J; Gregory P; Naylor J; Haskins K; Jones B
J Immunol; 1997 Dec; 159(12):5936-45. PubMed ID: 9550391
[TBL] [Abstract][Full Text] [Related]
16. Induction of broadly neutralizing antibodies against measles virus mutants using a polyepitope vaccine strategy.
Bouche FB; Steinmetz A; Yanagi Y; Muller CP
Vaccine; 2005 Mar; 23(17-18):2074-7. PubMed ID: 15755573
[TBL] [Abstract][Full Text] [Related]
17. Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus.
Obeid OE; Stanley CM; Steward MW
Virus Res; 1996 Jun; 42(1-2):173-80. PubMed ID: 8806185
[TBL] [Abstract][Full Text] [Related]
18. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M
Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
Staats HF; Nichols WG; Palker TJ
J Immunol; 1996 Jul; 157(1):462-72. PubMed ID: 8683152
[TBL] [Abstract][Full Text] [Related]
20. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
